Scarica l'app Stockscreener
40.07
1.42%
0.56
Dopo l'orario di chiusura:
40.29
0.22
+0.55%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Rigel Pharmaceuticals Borsa (RIGL) Ultime notizie
Published on: 2025-08-16 07:20:24 - Newser
Key metrics from Rigel Pharmaceuticals Inc.’s quarterly data2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
Is Rigel Pharmaceuticals Inc. a candidate for recovery playJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - Newser
Published on: 2025-08-16 02:21:32 - Newser
Automated trading signals detected on Rigel Pharmaceuticals Inc.CPI Data & Weekly Breakout Watchlists - Newser
What indicators show strength in Rigel Pharmaceuticals Inc.Trade Performance Summary & Fast Exit and Entry Strategy Plans - Newser
Will a bounce in Rigel Pharmaceuticals Inc. offer an exitJuly 2025 Pullbacks & Expert Verified Movement Alerts - Newser
Has Rigel Pharmaceuticals Inc. found a price floorExit Point & Daily Stock Trend Reports - Newser
Sector ETF performance correlation with Rigel Pharmaceuticals Inc.2025 Dividend Review & Community Consensus Trade Signals - Newser
Forecasting Rigel Pharmaceuticals Inc. price range with options data2025 AllTime Highs & Daily Chart Pattern Signals - Newser
What are Rigel Pharmaceuticals Inc.’s recent SEC filings showingMarket Growth Review & Weekly Stock Breakout Alerts - newsimpact.co.kr
Can volume confirm reversal in Rigel Pharmaceuticals Inc.July 2025 Movers & Safe Capital Investment Plans - Newser
Published on: 2025-08-15 05:51:08 - sundaytimes.kr
Warm Autoimmune Hemolytic Anemia Market to Observe Significant Growth During the Forecast Period | Rigel Pharmaceuticals, Apellis Pharmaceuticals, Inc., Johnson & Johnson, Sanofi, Incyte Corporation - Barchart.com
Rigel Pharmaceuticals Inc. Recovery Linked to Earnings SurprisePortfolio Update Summary & Free Growth Oriented Trading Recommendations - classian.co.kr
Rigel Pharmaceuticals Q2 Earnings Boost Breakout Potential - AInvest
Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout - Seeking Alpha
Rigel Pharmaceuticals (RIGL) up more than 100% since Jul 18 - AInvest
Using Python tools to backtest Rigel Pharmaceuticals Inc. strategiesJuly 2025 Decliners & Breakout Confirmation Alerts - Newser
Rigel Pharmaceuticals' Earnings Mask Underlying Cash Flow Concerns - AInvest
Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable Quality - Yahoo Finance
Technical signs of recovery in Rigel Pharmaceuticals Inc.Oversold Stock Bounce Playbook Generator - Newser
H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT - Insider Monkey
RIPK1 Inhibitor Pipeline Outlook Report 2025: Key 10+ Companies and Breakthrough Therapies Shaping the Future Landscape - The Globe and Mail
Best Momentum Stock to Buy for August 8th - MSN
Rigel targets up to $280M 2025 revenue as IRA boosts sales and pipeline advances - MSN
Cantor Fitzgerald Analysts Boost Earnings Estimates for RIGL - Defense World
HC Wainwright Issues Positive Estimate for RIGL Earnings - Defense World
Earnings Estimates Moving Higher for Rigel (RIGL): Time to Buy? - Yahoo Finance
Top 5 Stocks with Strong Price Performance to Buy Now - AInvest
5 Best Stocks With Relative Price Strength to Buy Right Now - sg.finance.yahoo.com
Results: Rigel Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance
New Strong Buy Stocks for August 8th - TradingView
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q2 2025 Earnings Call Transcript - Insider Monkey
Rigel Pharmaceuticals Flips To A Profit On Rising Sales - Finimize
Jefferies Reaffirms Their Hold Rating on Rigel (RIGL) - The Globe and Mail
Rigel Pharmaceuticals (RIGL) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Finance
Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Citi Analysts Maintain Buy Rating on Rigel with $67 Price Target - AInvest
Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap Up on Better-Than-Expected Earnings - Defense World
Rigel Pharmaceuticals (RIGL) Q2 Earnings and Revenues Surpass Estimates - MSN
Rigel Pharmaceuticals’ Earnings Call Highlights Robust Growth - TipRanks
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - 富途牛牛
Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $67 - 富途牛牛
Rigel Pharmaceuticals (NASDAQ:RIGL) Shareholder Returns Have Been Solid, Earning 160% in 1 Year - 富途牛牛
Cantor Fitzgerald Raises Price Target for RIGL to $32.00, Mainta - GuruFocus
Rigel Pharmaceuticals shares surge 16.67% intraday after strong Q2 earnings and revenue guidance. - AInvest
Rigel Pharmaceuticals: Cantor Fitzgerald Maintains Neutral, PT Raised to $32 from $23. - AInvest
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Held Back By Insufficient Growth Even After Shares Climb 28% - simplywall.st
Rigel (RIGL) Q2 Revenue Jumps 176% - The Globe and Mail
Rigel (RIGL) Q2 Revenue Jumps 176% - The Motley Fool
Jefferies raises Rigel Pharmaceuticals stock price target on strong sales By Investing.com - Investing.com Nigeria
Jefferies raises Rigel Pharmaceuticals stock price target on strong sales - Investing.com
RIGL files S-8 to register 825,000 shares for employee equity plans | RIGL SEC FilingForm S-8 - Stock Titan
Rigel Pharmaceuticals Q2 2025 Earnings Call Transcript - MarketBeat
Rigel: Q2 Earnings Snapshot - New Haven Register
TR | OpenAI4o Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $25 - 富途牛牛
1.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):